United States · FDA National Drug Code directory

Norvir

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0074-3399_08f28b14-eabc-4a9a-b066-d8eda837e9e4
Product NDC
0074-3399
Form
POWDER
Composition / generic term
Ritonavir
Labeler
AbbVie Inc.
Marketing category
NDA
Marketing start / end (source format)
20170607
Source listing expiry
20271231

Source-listed ingredients

  • RITONAVIR — 100 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 PACKET in 1 CARTON (0074-3399-30) / 1 POWDER in 1 PACKET · 0074-3399-30

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →